|
|
In the United States, an estimated 50 million unnecessary antibiotics are prescribed for viral respiratory infections.
About 100 new prescription or over-the-counter drugs come into the U.S. market every year.
Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.
Women are 50% to 75% more likely than men to experience an adverse drug reaction.
In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.